Skip to main content

Uric acid in the early risk stratification of ST-elevation myocardial infarction

Internal and Emergency Medicine volume 7, pages 33–39 (2012)Cite this article

An Erratum to this article was published on 25 October 2016

Abstract

Controversy still exists about uric acid as a potential prognosticrisk factor for outcomes in patients with acute myocardial infarction. We prospectively assessed, in 856 patients with ST-elevation myocardial infarction (STMI) consecutively admitted to our Intensive Cardiac Care Unit after primary percutaneous coronary intervention (PCI) whether uric acid (UA) levels are associated with in-hospital mortality and complications. Killip classes III-–IV were more frequent in the 3° UA tertile that was associated with the highest values of peak Tn I (p = 0.005), NT-proBNP (p < 0.001), and fibrinogen (p = 0.036). Uric acid was associated with mortality (crude OR: 1.24; 95% CI 1.03–1.51; p = 0.025), but, when adjusted for Tn I and renal failure (as inferred by eGFR <60 ml/min/1.73 m2), uric acid lost its statistical significance, while Tn I (100 pg/ml step OR: 1.002; 95% CI 1.000–1.003; p = 0.007) and renal failure (OR 9.16; 95% CI 3.60–23.32; p < 0.001) were independent predictors for in-ICCU mortality. Uric acid remained as independent predictor for in-ICCU complications (1 mg/dl step OR: 1.11; 95% CI 1.01–1.21; p = 0.030) together with admission glycemia (1 g/dl step OR: 1.50; 95% CI 1.19–1.91; p < 0.001) and renal failure (OR: 1.46; 95% CI 0.99–2.16; p < 0.001). In STEMI patients submitted to PCI, increased uric acid levels identify a subgroup more prone to in-ICCU complications, probably because hyperuricemia stems from several complex mechanisms ranging from pre-existing risk factors to the degree of myocardial ischemia (as indicated by Killip class, ejection fraction) and to the acute metabolic response (as inferred by glucose levels). Hyperuricemia is not independently associated with early mortality when adjusted for renal function and the degree of myocardial damage.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811–1821

    PubMed  Article  CAS  Google Scholar 

  2. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40:437–442

    PubMed  Article  CAS  Google Scholar 

  3. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190

    PubMed  Article  CAS  Google Scholar 

  4. Kang D (2010) Potential role of uric acid as a risk factor for cardiovascular disease. Korean J Internal Med 25:18–20

    Article  CAS  Google Scholar 

  5. Gagliardi AC, Miname MH, Santos RD (2009) Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202(1):11–17

    PubMed  Article  CAS  Google Scholar 

  6. Strazzullo P, Puig JG (2007) Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 17(6):409–414

    PubMed  Article  CAS  Google Scholar 

  7. Lehto S, Niskanen L, Rönnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29(3):635–639

    PubMed  Article  CAS  Google Scholar 

  8. Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34(8):1951–1956

    PubMed  Article  Google Scholar 

  9. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D et al (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107(15):1991–1997

    PubMed  Article  Google Scholar 

  10. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G et al (2002) Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89(1):12–17

    PubMed  Article  CAS  Google Scholar 

  11. Nadkar MY, Jain VI (2008) Serum uric acid in acute myocardial infarction. J Assoc Physicians India 56:759–762

    PubMed  CAS  Google Scholar 

  12. Homayounfar S, Ansari M, Kashani KM (2007) Evaluation of independent prognostic importance of hyperuricemia in hospital death after acute myocardial infarction. Saudi Med J 28(5):759–761

    PubMed  Google Scholar 

  13. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S et al (2005) Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 96:489–495

    PubMed  Article  CAS  Google Scholar 

  14. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF (2010) Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers A single center experience. Int J Cardiol 138:206–216

    PubMed  Article  Google Scholar 

  15. Celik T, Iyisoy A (2009) Uric acid levels for the prediction of prognosis in patients with acute ST elevation myocardial infarction: a new potential biomarker. In J Cardiol. doi:10.1016/j.ijcard.2008.12.073

  16. Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A et al (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1):84–89

    PubMed  Article  Google Scholar 

  17. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 28(20):2525–2538

    PubMed  Article  Google Scholar 

  18. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Int Emerg Med (Epub ahead of print)

  19. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Int Emerg Med (Epub ahead of print)

  20. Lazzeri C, Valente S, Chiostri M, Picariello C and Gensini GF (2010) In hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Card Prev Rehab (in press)

  21. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis. Int Emerg Med 5(1):61–66

    Article  Google Scholar 

  22. Ward HJ (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352(9129):670–671

    PubMed  Article  CAS  Google Scholar 

  23. Kanellis J, Watanabe S, Li JH, Kang DH, Li P et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41(6):1287–1293

    PubMed  Article  CAS  Google Scholar 

  24. Ferroni P, Basili S, Paoletti V, Davì G (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16(3):222–233

    PubMed  Article  CAS  Google Scholar 

  25. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11(32):4145–4151

    PubMed  Article  CAS  Google Scholar 

  26. Zweier JL, Kuppusamy P, Lutty GA (1988) Measurement of endothelial cell free radical generation: evidence for a central mechanisms of free radical injury in post ischemic tissue. Proc Natl Acad Sci 85:4046–4050

    PubMed  Article  CAS  Google Scholar 

  27. Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742

    PubMed  Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Affiliations

  1. Intensive Cardiac Care Unit, Heart and Vessel Department, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50134, Florence, Italy

    Chiara Lazzeri, Serafina Valente, Marco Chiostri, Claudio Picariello & Gian Franco Gensini

Authors
  1. Chiara Lazzeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serafina Valente
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Chiostri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudio Picariello
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gian Franco Gensini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chiara Lazzeri.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s11739-016-1556-x.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lazzeri, C., Valente, S., Chiostri, M. et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med 7, 33–39 (2012). https://doi.org/10.1007/s11739-011-0515-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-011-0515-9

Keywords

  • Uric acid
  • Risk stratification
  • ST-elevation myocardial infarction
  • Percutaneous coronary intervention